147
Views
5
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

HIF-1α inhibition as a novel mechanism of cardiac glycosides in cancer therapeutics

Evaluation of: Zhang H, Qian DZ, Tan YS, et al. Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth. Proc Natl Acad Sci USA 2008;105:19579-86

&
Pages 241-243 | Published online: 21 Jan 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Natalia Prevarskaya, Roman Skryma & Yaroslav Shuba. (2013) Targeting Ca2+ transport in cancer: close reality or long perspective?. Expert Opinion on Therapeutic Targets 17:3, pages 225-241.
Read now

Articles from other publishers (4)

Honey Pavithran, Angelina Job Kolady & Ranjith Kumavath. 2023. Computational Methods in Drug Discovery and Repurposing for Cancer Therapy. Computational Methods in Drug Discovery and Repurposing for Cancer Therapy 237 258 .
Evelyn M. Flahavan, Linda Sharp, Kathleen Bennett & Thomas I. Barron. (2014) A cohort study of digoxin exposure and mortality in men with prostate cancer. BJU International 113:2, pages 236-245.
Crossref
Michael E. Jung & Mikhail Guzaev. (2013) Studies Toward the Enantiospecific Total Synthesis of Rhodexin A. The Journal of Organic Chemistry 78:15, pages 7518-7526.
Crossref
Michael E. Jung & Dongwon Yoo. (2011) First Total Synthesis of Rhodexin A. Organic Letters 13:10, pages 2698-2701.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.